MiR‐200c‐3p as a novel genetic marker and therapeutic tool for alopecia areata
Skin Research and Technology · 2024
DOI: 10.1111/srt.13639 ↗At a glance
Journal article in Skin Research and Technology, 2024. Written by Ahmed Ibrahim AbdElneam and 3 co-authors. Institution: Department of Clinical Biochemistry, Department of Basic Medical Sciences, College of Medicine, Shaqra University, Dawadmi, Saudi Arabia. Major MEDLINE topics: Alopecia Areata, MicroRNAs. Cited 8 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Background
MicroRNAs (miRNAs) are small RNA molecules that regulate gene expression in diverse biological processes. They hold promise as therapeutic candidates for targeting human disease pathways, although our understanding of their gene regulatory mechanism remains incomplete. Alopecia areata (AA) is a prevalent inflammatory ailment distinguished by the infiltration of T cells targeting the anagen‐stage hair follicles. The scarcity of effective remedies for AA may stem from limited understanding regarding its precise cellular mechanism.
Aim
To investigate and examine the importance and role of the miR‐200c‐3p as a genetic indicator for AA, and its possible impact on disease progression. Subjects and methods Case‐control study included 65 patients with AA and 65 matched healthy controls. A real‐time PCR technique was used to measure the expression of miR‐200c‐3p for both groups. Bioinformatic tools were used for prediction with genes and gene‐gene interaction, and protein‐protein interaction.
Results
The expression levels of miR‐200c‐3p were significantly higher in AA patients than in healthy controls. We predicted that miR‐200c‐3p plays a markable role in the development of AA by its effect on the EGFR tyrosine kinase inhibitor resistance pathway.
Conclusion
We were able to identify the influence of miR‐200c‐3p on both PLCG1 and RPS6KP1 genes which in turn regulate the EGFR tyrosine kinases resistance pathway that displayed the most substantial increase in activity. Our outcomes shed light on the era of the potential theranostic role of this innovative miRNA in AA.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Clinical Biochemistry, Department of Basic Medical Sciences, College of Medicine, Shaqra University, Dawadmi, Saudi Arabia.
- Molecular Genetics and Enzymology Department, Human Genetics and Genome Research Institute, National Research Center, Dokki, Cairo, Egypt.
- Departments of Dermatology, College of Medicine, Shaqra University, Dawadmi, Saudi Arabia.
- Department of Microbiology and Immunology, Faculty of Medicine and Health Sciences, Sana'a University, Sanaa, Yemen.
- Divisions of Dermatology and Cutaneous Surgery, College of Medicine, Qassim University, Buraydah, Saudi Arabia.
ORCID profiles: Ahmed Ibrahim AbdElneam, Mohammed Saleh Al-Dhubaibi, Saleh Salem Bahaj, Ghadah Alhetheli
Cite
APA
AbdElneam, A. I., Al-Dhubaibi, M. S., Bahaj, S. S., & Alhetheli, G. (2024). MiR‐200c‐3p as a novel genetic marker and therapeutic tool for alopecia areata. Skin Research and Technology. https://doi.org/10.1111/srt.13639
Vancouver
AbdElneam AI, Al-Dhubaibi MS, Bahaj SS, Alhetheli G. MiR‐200c‐3p as a novel genetic marker and therapeutic tool for alopecia areata. Skin Research and Technology. 2024. doi:10.1111/srt.13639
BibTeX
@article{AbdElneam2024,
author = {AbdElneam, Ahmed Ibrahim and Al-Dhubaibi, Mohammed Saleh and Bahaj, Saleh Salem and Alhetheli, Ghadah},
title = {MiR‐200c‐3p as a novel genetic marker and therapeutic tool for alopecia areata},
journal = {Skin Research and Technology},
year = {2024},
doi = {10.1111/srt.13639}
}
EUVIMED